Show simple item record

dc.contributor.authorFadzen, Colin M.
dc.contributor.authorHolden, Rebecca Lynn
dc.contributor.authorWolfe, Justin
dc.contributor.authorChoo, Zi-Ning
dc.contributor.authorSchissel, Carly K.
dc.contributor.authorYao, Monica
dc.contributor.authorHanson, Gunnar J.
dc.contributor.authorPentelute, Bradley L.
dc.date.accessioned2020-10-15T17:04:23Z
dc.date.available2020-10-15T17:04:23Z
dc.date.issued2019-08
dc.date.submitted2019-08
dc.identifier.issn0006-2960
dc.identifier.issn1520-4995
dc.identifier.urihttps://hdl.handle.net/1721.1/128007
dc.description.abstractPhosphorodiamidate morpholino oligonucleotides (PMOs) make up a promising class of therapeutics for genetic disease. PMOs designed for "exon skipping" must be internalized into cells, reach the nucleus, and act on pre-mRNA to mediate their effects. One tactic for improving PMO delivery and exon skipping is to covalently conjugate PMOs to cell-penetrating peptides (CPPs). Here, we report the synthesis of PMOs conjugated to CPP chimeras, constructed by combining multiple CPPs into one sequence. The chimeric CPPs synergistically improve PMO activity up to 70-fold compared to that of the PMO alone and beyond the expected effects of each component peptide. By investigating the design space of CPP chimeras, we demonstrate that all components must be covalently attached, that the order of the two sequences matters, and that peptide identity can tune activity. We identified one chimera (pVEC-Bpep) to investigate in more detail and found that it engages mechanisms of endocytosis different from those of its parent peptides. We also examined the extent to which the beneficial effect comes from improved cellular uptake as opposed to the downstream steps required for exon skipping. Given the complexity of intracellular delivery, we anticipate this work will lead researchers to consider combining molecules with different physicochemical properties to aid in the delivery of biologic cargoes.en_US
dc.description.sponsorshipNational Institutes of Health (Award F30HD093358)en_US
dc.language.isoen
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/acs.biochem.9b00413en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceProf. Pentelute via Ye Lien_US
dc.titleChimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacyen_US
dc.typeArticleen_US
dc.identifier.citationFadzen, Colin M. et al. "Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy." Biochemistry 58, 38 (August 2019): 3980–3989 © 2019 American Chemical Societyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Center for Environmental Health Sciencesen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalBiochemistryen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-10-06T17:04:58Z
dspace.orderedauthorsFadzen, CM; Holden, RL; Wolfe, JM; Choo, Z-N; Schissel, CK; Yao, M; Hanson, GJ; Pentelute, BLen_US
dspace.date.submission2020-10-06T17:05:05Z
mit.journal.volume58en_US
mit.journal.issue38en_US
mit.licensePUBLISHER_POLICY
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record